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Effusin A (1), a spirobicyclic N,O-acetal derivative with an unprecedented 3',3a',5',6'-
tetrahydrospiro[piperazine-2,2'-pyrano[2,3,4-de]chromene] ring system, and a spiro-polyketide-
diketopiperazine hybrid dihydrocryptoechinulin D (2) were isolated from a mangrove rhizosphere soil 
derived fungus, Aspergillus effuses H1-1. Their structures were determined by detailed spectroscopic 10 
analysis. Effusin A (1) and dihydrocryptoechinulin D (2) occurred as racemates, the enantiomers of which 
were separated and characterized by online HPLC-ECD analysis and their absolute configurations were 
determined by the solution TDDFT ECD calculation approach. The cytotoxic effects of 1 and 2 were 
preliminarily evaluated and 2 showed potent activity on P388 cells with IC50 value of 1.83 µM. The target 
of racemic 2 were also investigated and the (12R, 28S, 31S)-2 enantiomer showed selectivity against 15 
topoisomerase I. 
Introduction 
Fungi belonging to the genus Aspergillus are an attractive source 
of secondary metabolites with high structural diversities and 
interesting bioactivities, including pharmaceuticals such as the 20 
cholesterol-lowering drug lovastatin, psychoactive compounds 
such as xenovulene, and toxins such as aflatoxin B1.1 In our 
ongoing search for bioactive novel compounds from marine-
derived fungi, a strain identified as Aspergillus effuses H1-1 was 
isolated from the mangrove rhizosphere soil collected in the coast 25 
of Fujian province, China. The chemical study led to the isolation 
of two new spiro-polyketide-diketopiperazine alkaloids, named 
effusin A (1) and dihydrocryptoechinulin D (2)2 (Fig. 1). In this 
paper, the isolation, structural elucidation and bioactivities of 
compounds 1 and 2 are reported. 30 
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Fig. 1. Structures of enantiomers 1-2. 
Results and Discussion 
The fermented whole broth (70 L) gave a crude extract (76 g). 
The extract was separated by repeated silica gel column 35 
chromatography and finally semi-prep. ODS HPLC to yield 
compounds 1 (28 mg) and 2 (23 mg). 
Effusin A (1) was obtained as a colorless solid. High-resolution 
electrospray mass spectrometry (HRESIMS) revealed ion at m/z 
652.3377 ([M-H]-), indicating a molecular formula of 40 
C39H47N3O6 (calcd. for C39H46N3O6, 652.3387). Its IR 
absorptions suggested the presence of hydroxyl, secondary amine 
(3428, 3368, 3195 cm-1) and secondary amide (1693 and 1624 
cm-1) groups. The UV-vis absorptions at λmax 358, 285 and 225 
nm were characteristic of a dehydrotryptophan moiety.3 45 
In the NMR spectrum, the dehydrotryptophan moiety was 
confirmed by the HMBC correlations from H-8 (δH 7.12) to C-2 
(δC 144.7), C-3a (δC 126.3), and C-10 (δC 162.8), and from NH-1 
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(δH 11.13) to C-2 and C-7a (δC 135.1) (Fig. 2). The 1,1-dimethyl-
2-propenyl group was attached to C-2 based on the HMBC 
correlations from H-18 (δH 1.47) and H-19 (δH 1.51) to C-2. A 
diketopiperazine ring was deduced based on the two amide 
carbonyl carbons (δC 162.8, C-1; 162.7, C-13) observed in 13C 5 
NMR spectrum and the HMBC correlations from NH-11 (δH 9.16) 
to C-9 (δC 124.0) and C-13 and from NH-14 (δH 9.67) to C-10 
and the oxidized C-12 (δC 84.7) (Fig. 2). The isochroman moiety 
with a pentyl side-chain was deduced by the 1H-1H COSY 
correlations (H-28/H-29/H-30/H-31/H-32/H-33/H-34) and the 10 
HMBC correlations from H-28 (δH 4.39) to C-22 (δC 124.9) and 
C-26 (δC 149.7) and C-27 (δC 117.5), from OH-26 (δH 9.30) to C-
26 and C-27, and from H-35 (δH 3.16) to C-23 (δC 140.3), C-24 
(δC 130.2) and C-25 (δC 114.1), as well as the NOE enhancement 
of H-20b (δH 1.96) when H-29 (δH 3.49) was irradiated (Fig. 2). 15 
The prenyl group (from C-35 to C-39) was also deduced by the 
1H-1H COSY correlations (H-35/H-36) and HMBC correlations 
from H-38 (δH 1.54) and H-39 (δH 1.60) to C-36 (δC 121.9) and 
C-37 (δC 132.1) (Fig. 2). The methoxyl was attached to C-28 
evidenced by the HMBC correlation (Fig. 2). Then the planar 20 
structure of 1 was established by connection between C-12 and 
C-21 via C-20 based on the 1H-1H COSY (H-20/H-21) and 
HMBC correlations from H-20 (δH 2.73, 1.96) to C-12 (δC 84.7), 
C-13 (δC 162.7) and C-22, together with the connection of C-12 
and C-23 via an oxygen according to the molecular formula, and 25 


























































































Fig. 2 Key 1H-1H COSY, HMBC and NOE correlations of 1 and 
2. 
The relative stereochemistry of 1 was deduced as 30 
(12R*,21R*,28R*,29R*) on the basis of selective NOE difference 
experiments (Fig. 2). When H-29 (δH 3.49) was irradiated, the 
signals of H-28 (δH 4.39) and H-20b (δ 1.96) were enhanced, 
which revealed that these three hydrogens located at the same 
side. The enhancement of H-21 (δH 5.02) and NH-11 (δH 9.16) 35 
upon irradiation of H-20a (δ 2.73) indicated the cis relative 
configuration of H-20a, H-21 and the proximity of NH-11. 
Additionally, the Z-geometry of the ∆8 double bond was deduced 
from the downfield shift of H-8 (δH 7.12) attributed to the 
deshielding effect of the carbonyl group on β-vinyl protons.3 This 40 
was also in agreement with the lack of NOE effect between H-8 
and H-14. 
Table 1. The 1H (600 MHz), and 13C NMR (150 MHz) data of 1 
and 2 in [D6]DMSO. 
 1  2 
Atom 
no. 
δC δH mult.(J in Hz)  δC δH mult.(J in Hz) 
1  11.13, s   11.05, s 
2 144.7  
  
144.2   
3 104.0  
  
103.6   
3a 126.3  
  
127.1   
4 119.4  7.34, d (7.8)  118.8  7.07, m 
5 119.4  6.96, dd (7.8, 7.3)  119.4  7.00, dd (7.8, 6.9) 
6 120.8  7.07, dd (7.8, 7.3)  120.7  7.07, m 
7 111.5  7.42, d (7.8)  111.6  7.41, d (8.2) 
7a 135.1  
  
135.1   
8 113.7  7.12, s  110.7   
9 124.0  
  
124.4   
10 162.8  
  
168.3   
11  9.16, s   7.71, s 
12 84.7  
  
59.7   
13 162.7  
  
161.3   
14  9.67, s   8.86, s 
15 39.7  
  
39.2   
16 145.1  6.09, dd (17.2, 10.8)  145.1  6.05, dd (17.2, 10.3) 
17 111.8 
 
5.09, bd (10.8) 
5.07, bd (17.2)  
111.7 
 
5.01, d (17.2) 
5.03, d (10.3) 
18 27.9 
 1.47, s  27.5  1.45, s 
19 27.4 
 1.51, s  27.6  1.47, s 
20 35.1 
 
a:2.73, dd (12.4, 6.3) 
b:1.96, dd (12.4, 11.0)  
117.2   
21 64.7  5.02, dd (11.0, 6.3)  153.4   
22 124.9  
  
127.1   
23 140.3  
  
125.2  6.92, s 
24 130.2  
  
146.8   
25 114.1  6.61, s  128.0   












28 69.4  4.39, brs  39.7  2.74, m 
29 73.5  3.49, t (6.6)  126.1  5.78, brd (10.3) 
30 31.0 
 1.65, m  131.8  5.71, brd (10.3) 
31 25.0 
 1.41, m  28.0  2.58, m 
32 31.3 




1.74, dd (13.7, 2.8) 
2.08, dd (13.7, 7.3) 
33 22.1 
 1.33, m  21.6  1.10, d (7.4) 
34 14.0 
 0.88, t (6.9)  196.9  10.18, s 
35 27.4 
 3.16, m  26.6  3.12, m 
36 121.9  5.22, brt (7.3)  121.7  5.16, brt (7.3) 
37 132.1  
  
132.5   
38 17.5 
 1.54, s  17.6  1.62, s 
39 25.4 C
 1.60, s  25.5  1.67, s 
OCH3 56.2 















 9.05, s 
Since effusin A (1) had zero specific rotation and a baseline 45 
ECD curve, 1 was supposed to be a racemate, which was 
confirmed by the baseline separation of its enantiomers by chiral 
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HPLC using Chiralpak IC column (Fig. 3B). The separated 
enantiomers were characterized by their online HPLC-ECD 
spectra, which had been found an efficient tool to study 
stereoisomeric mixtures of natural products.4,5,6 The HPLC-ECD 
spectra of the enantiomers showed mirror image curves (Fig. 3C), 5 
and the first-eluting enantiomer (1a) had a broad negative Cotton 
effect (CE) at 349 nm, positive ones at 283 and 234 nm, and a 
negative one at 211 nm. The DFT reoptimization of the 30 (for 
computational procedure see Table S1, SI) initial MMFF 
conformers was carried out on the truncated model compound 1a′ 10 
(C-29 n-pentyl group in 1a was replaced by methyl) at the 
B3LYP/6-31G(d) level, which afforded two major conformers 
with 64.8% (conf. A) and 30.6% population (conf. B) (Fig. 3A) 
above 3% population. The two conformers differed in the 
orientation of the C-2 and C-24 alkenyl substituents. The ECD 15 
spectra of the arbitrarily chosen (12R, 21R, 28R, 29R) enantiomer 
(1a′) were calculated with various functionals (B3LYP, 
BH&HLYP, PBE0) and 6-311G(d,p) basis set. All the 
Boltzmann-weighted ECD spectra reproduced well the 
experimental curve of the first-eluting enantiomer  (1a) with 20 
PBE0 giving the best agreement (Fig. 3D), which allowed the 
determination of the absolute configuration of the first-eluting 
enantiomer (1a) as (12R, 21R, 28R, 29R). Consequently, the 
sencond-eluting enantiomer (1b) was also determined as (12S, 




Fig. 3 DFT optimized conformational isomers of the truncated 
model compound of (12R, 21R, 28R, 29R)-1 (1a′) above 3% and 30 
their Boltzmann populations obtained by B3LYP/6-31G(d) (A); 
HPLC spectrum of 1 on a chiral phase (B); HPLC-ECD spectra 
of the separated enantiomers of effusin A (1); first-eluting 
enantiomer (1a) (red curve) and second-eluting enantiomer (1b) 
(blue curve) (C) and solution ECD spectrum of 1a (peak 1, black 35 
curve) compared with the PBE0/6-311G(d,p) computed ECD 
spectrum for the truncated model of 1a′ obtained as the 
Boltzmann-weighted average of the solution conformers. Bars 
represent the rotatory strengths of the lowest-energy conformer 
(D).  40 
Dihydrocryptoechinuline D (2) was obtained as a yellow solid. 
Its molecular formula was determined as C38H43N3O5 according 
to the positive HRESIMS peak at m/z 622.3256 [M+H]+ (calcd. 
622.3281). It’s IR and UV-Vis spectra were very similar to those 
of cryptoechinuline D,7 which suggested the presence of 45 
dehydrotryptophan and diketopiperazine moieties.3 
The 1H and 13C NMR spectra of 2 were very similar to 
cryptoechinuline D, except the appearance of two sp3 methylene 
signals (CH2-26: δH 2.88, 3.07; δC 20.9 and CH2-27: δH 1.54, δC 
32.7) instead of two sp2-hybridized carbons in cryptoechinuline 50 
D. This suggested that 2 was the dihydro analogue of 
cryptoechinuline D. This assumption was confirmed by 1H-1H 




Fig. 4 Conformational isomers of (12S, 28R, 31R)-2 (2b) above 
3% and their Boltzmann populations obtained by B3LYP/6-
31G(d) reoptimizations (A); HPLC spectrum of 2 on a chiral 60 
phase (B); the ECD spectra of the seprated enantiomers of 2, 
first-eluting enantiomer (2a) (red curve), second-eluting 
enantiomer  (2b) (blue curve) (C); and the comparison of the 
ECD spectrum of 2a (black curve) to the calculated one of 
(12S,28R,31R)-2 (red curve) (D).  65 
In the selective NOE experiments (Fig. 2), when H-33 (δH 1.10) 
was irradiated, the signals of H-32b (δH 1.74) and NH-11 (δH 7.71) 
were enhanced, indicating the β orientation of these protons. The 

































































































 4  |  Journal Name, [year], [vol], 00–00 This journal is © The Royal Society of Chemistry [year] 
enhancement of H-32a (δH 2.08) upon irradiation of H-31 (δH 
2.58) indicated that they were at the same side. Although no 
enhancement of hydrogen signals was observed when H-28 was 
irradiated, the relative stereochemistry of C-28 could be deduced 
the same as cryptoechinulin D,8 which was also isolated from this 5 
strain, from the biosyntheses opinions. 
Similarly to effusin A (1), dihydrocryptoechinuline D (2) was 
also a racemic mixture as justified by the zero specific rotation 
and baseline ECD curve. The enantiomers were separated on a 
Chiralpak IC column and mirror image HPLC-ECD curves were 10 
recorded (Fig. 4B, 4C). Since the enantiomers of 
dihydrocryptoechinuline D (2) exhibited quite different ECD 
curves from those of effusin A (1), TDDFT ECD calculation was 
used again to determine the absolute configuration. The initial 
MMFF conformational search provided 72 conformers, the DFT 15 
reoptimization of which reduced the number of conformers to 
two above 3% population. The two conformers had 82.2% and 
4.4% population (Fig. 4A), and they were used for the calculation 
of the ECD spectrum. The Boltzmann-weighted TDDFT ECD 
spectra of (12S, 28R, 31R)-2 were mirror image of the 20 
experimental HPLC-ECD of the first eluting enantiomer except 
for the lowest-energy transition, which suggested that the first 
eluting enantiomer (2a)  has (12R, 28S, 31S) absolute 
configuration (Fig. 4D). A patent application for 
dihydrocryptoechinuline D (2) had been submitted in China 25 
describing the new structure and its cytotoxicities against P388, 
HL-60, BEL-7402 and A-549 cell lines2 but the separation, 
determination of absolute configuration and the molecular target 
of the two enantiomers were not mentioned. 
Effusin A (1) contains a spirobicyclic N,O-acetal moiety, 30 
which could be obtained by a domino ring-closure reaction 
between the substituted salicylaldehyde moiety in aspergin and 
the eneamide moiety of diketopiperazine unit in neoechinulin B. 
In contrast, an enzyme-catalyzed regiospecific [4+2] Diels-Alder 
reaction produces the spirobicycle of 2 (Scheme 1). Similar 35 
Diels-Alder biosynthetic reaction has already been suggested for 
a few recent examples such as yaoshanenolides and 
lanceolatins.9,10,11 Notably, all the key intermediates including 
neoechinulin B (3),3 isodihydroauroglaucin (4)12 and aspergin 
(5)13 were isolted from this fungus Aspergillus effuses H1-1, 40 
which supported the biosynthetic hypothesis. 
 
Scheme 1. Plausible biosynthetic pathway to 1 and 2 
Spiro-polyketide-diketopiperazines are rare in nature. To the 
best of our knowledge, only few examples belonging to this kind 45 
of spirocyclic alkaloids, variecolortides A-C14 and 
cryptoechinuline D,7 were reported, and their absolute 
configurations have not been reported yet. The synthesis of 
racemic variecolortide A and B has been recently reported by 
exploiting a hetero Diels-Alder reaction of a 1,4-anthraquinone 50 
with a didehydrodiketopiperazine to form the central spiro-cyclic 
core.15 
The cytotoxic effects of 1 and 2 were preliminarily evaluated 
on P388, HL-60, BEL-7402 and A-549 cell lines (Table 2). 
Compound 2 showed remarkable activities with IC50 values of 55 
1.83 and 4.80 µM on P388 and HL-60 cells, respectively.2  




P388 HL-60 BEL-7402 A-549 
1 >100 >100 85.2 ± 0.08 >100 
2 1.83 ± 0.21 4.80 ± 0.34 >100 17.1 ± 0.16 
Doxorubicin 0.33 ± 0.002 0.05± 0.001 0.244 ± 0.019 0.0799 ± 0.0058 
The molecule targets of racemic 2 were investigated by using 
various models including topoisomerase I, topoisomerase II, and 60 
Hsp90. The inhibitory activity only was observed on 
topoisomerase I assayed by relaxation of supercoiled plasmid 
DNA at 100 µM. To investigate the influence of absolute 
configurations on the activity, the separated enantiomers (2a and 
2b) of 2 were tested on topoisomerase I. Interestingly, (12R, 28S, 65 
31S)-2 (2a) showed moderate activity against topoisomerase I  
than 2, while 2b was almost inactive (Fig. 5). 
 
Fig. 5 Effects of 2, (12R, 28S, 31S)-2 (2a) and (12S, 28R, 31R)-2 
(2b) on Topo I-mediated supercoiled pBR322 relaxation 70 
Experimental Section 
General  
 Specific rotations were obtained on a JASCO P-1020 digital 
polarimeter. UV spectra were recorded on a Beckman DU 640 
spectrophotometer. IR spectra were taken on a Nicolet Nexus 470 75 
spectrophotometer in KBr discs. NMR spectra were recorded on a 
JEOL JNM-ECP 600 spectrometer using TMS as internal 
standard, and chemical shifts were recorded as δ values. ESIMS 
utilized on a Q-TOF Ultima Global GAA076 LC mass 
spectrometer. Semiprepartive HPLC was performed using an 80 
ODS column [HPLC :YMC-Pack ODS-A (5 µm, 10 × 250 mm, 4 
mL/min)]. HPLC-ECD spectra of 1 and 2 were run on a 
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Chiralpak IC column (5 µm, 150×4.6 mm, hexane/isopropanol 
eluent, 1 mL/min flow rate) and were recorded in stopped-flow 
mode on a JASCO J-810 electronic circular dichroism 
spectropolarimeter equipped with a 10 mm HPLC flow cell. TLC 
and column chromatography (CC) were performed on plates 5 
precoated with silica gel GF254 (10–40 µm) and over silica gel 
(200–300 mesh, Qingdao Marine Chemical Factory). Vacuum-
liquid chromatography (VLC) was carried out over silica gel H 
(Qingdao Marine Chemical Factory).  
Fungal Material 10 
 The working strain Aspergillus effuses H1-1 was isolated from 
the mud under mangrove along the coast of Fujian province, 
China. It was identified by Prof. Li Tian, the First Institute of 
Oceanography, SOA, Qingdao, China. The voucher specimen is 
deposited in the Key Laboratory of Marine Drugs, Chinese 15 
Ministry of Education. 
Fermentation and Extraction 
A small spoon of spore growing on potato dextrose agar slant was 
inoculated into 250 mL Erlenmeyer flask containing 75 mL 
culture medium consisting of glucose 2%, maltose 2%, 20 
monosodium glutamate 10%, beef extract 0.3%, KH2PO4 0.05%, 
MgSO4ּ7H2O 0.03% (in sea water) and cultured at 28˚C for two 
days on a rotary shaker at 160 rpm. Then 10 mL resultant seed 
culture was inoculated into 500 mL Erlenmeyer flask containing 
150 mL the above culture medium and incubated at 28˚C for 25 
seven days on a rotary shaker at 160 rpm. The fermented whole 
broth (70 L) was filtrated through cheesecloth to separate into 
broth supernatant and mycelium. The former was extracted three 
times with ethyl acetate to give an ethyl acetate solution. The 
latter was extracted three times with methanol, which was 30 
evaporated under reduced pressure to remove methanol to afford 
an aqueous solution. The aqueous solution was extracted three 
times with ethyl acetate to give another ethyl acetate solution. 
Both the ethyl acetate solutions were combined and concentrated 
in vacuo to give a crude extract (76 g). 35 
Purification 
The crude extract (76 g) was subjected to silica gel (200~300 
mesh) column packed in petroleum ether, and was separated into 
seven fractions (Fr.1 - Fr.7) using a step gradient elution of 
petroleum ether-chloroform and chloroform-methanol. The 40 
fraction (Fr.4), eluted with chloroform-methanol (100:1) solution 
from the silica gel column was further chromatographed 
gradiently on silica gel using chloroform-methanol (100:1~10:1) 
as elution and divided into 8 subfractions(Fr.4-1 - Fr.4-8). 
Subfraction Fr.4-1 yielded compound 1 (28 mg). Subfraction 45 
Fr.4-2 was separated by preparative HPLC on a ODS column 
using methanol-water (80:20) as eluting solvent to yield 
compound 2 (23 mg), and compound 2 (2.0 mg) were resolved to 
2a (0.8 mg) and 2b (0.8 mg) by HPLC on a chiral phase. The 
fraction, Fr.3, eluted with chloroform-methanol (200:1) solution 50 
from the silica gel column was further chromatographed 
gradiently on silica gel using chloroform-methanol (200:1~50:1) 
as elution and divided into 3 subfractions(Fr.3-1 - Fr.3-3). 
Subfraction Fr.3-1 yielded compound 3 (150 mg). The fraction 
(Fr.1), eluted with petroleum ether-chloroform (1:1) solution 55 
from the silica gel column was further chromatographed 
gradiently on silica gel using petroleum ether-chloroform 
(2:1~1:1) as elution and divided into 4 subfractions (Fr.1 - 1-Fr.1-
4). Subfraction Fr.4-1 yielded compound 4 (26 mg), and 
subfraction Fr.4-2 yielded compound 5 (98 mg). 60 
Effusin A (1): colorless solid (actone); UV (MeOH) λmax (log 
ε) 358 (3.62), 285 (3.60), 225 (4.12), 203 (4.38) nm; IR (KBr) 
νmax 3428, 3368, 3195, 3079, 2961, 2869, 1693, 1624, 1442, 
1377, 1079, 1036 cm-1; 1H NMR and 13C NMR data, Table 1; 
HRESIMS m/z 652.3377 [M-H]- (calcd for C39H46N3O6 65 
652.3387). 
(12R, 21R, 28R, 29R)-1 (1a): retention time (tR) 4.92 min 
(Chiralpak IC, hexane/isopropanol 85:15); ECD data were 
recorded as λmax (φ) by stopping the flow of the eluent 
(hexane/isopropanol 85:15) at the maximum concentration: 349 70 
(−13.87), 283 (5.75), 266sh (3.15), 245sh (3.38), 234 (12.09), 211 
(−25.17). 
(12S, 21S, 28S, 29S)-1 (1b): retention time (tR) 5.58 min 
(Chiralpak IC, hexane/isopropanol 85:15); ECD λmax (φ) in 
hexane/isopropanol 85:15: 346 (7.49), 279 (−3.46), 267sh 75 
(−2.69), 241sh (−2.78), 211 (12.99). 
Dihydrocryptoechinulin D (2): yellow solid (actone); UV 
(MeOH) λmax (log ε) 348 (3.76), 275 (3.86), 224 (4.21) nm; IR 
(KBr) νmax 3350, 3240, 3044, 2987, 2928, 1670, 1637, 1428, 
1380, 1271, 1253, 747 cm-1; 1H NMR and 13C NMR data, Table 80 
1; HRESIMS m/z 622.3256 [M+H]+ (calcd for C38H44N3O5 
622.3281). 
(12R, 28S, 31S)-2 (2a): [α]20D +204.8 (c 0.15, MeOH); 
retention time (tR) 5.48 min (Chiralpak IC, hexane/isopropanol 
70:30); ECD λmax (φ) in hexane/isopropanol 70:30: 402sh (1.07), 85 
382 (1.60), 335 (−2.96), 280sh (2.30), 249 (9.37), 223 (−7.09), 
209 (−7.16). 
(12S, 28R, 31R)-2 (2b): [α]20D −192.8 (c 0.15, MeOH); 
retention time (tR) 7.00 min (Chiralpak IC, hexane/isopropanol 
70:30); ECD λmax (φ) in hexane/isopropanol 70:30: 408sh 90 
(−0.83), 385 (−1.43), 342 (2.14), 282sh (−1.86), 248 (−7.35), 221 
(4.91), 210 (4.65). 
Bioassys 
Cell proliferation/viability assays: The maintance of HL-60, 
P388,  A-549, and BEL-740 cells, compound treatment, and MTT 95 
(HL-60 or P388)16 and SRB (A-549 or BEL-7402)17 assays for 
cell proliferation/viability were the same as those described 
previously. 
Topoisomerase I mediated DNA cleavage assay. 
Topoisomerases I were assayed by relaxation of supercoiled 100 
plasmid DNA. Relaxation of 250 ng of supercoiled by 
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topoisomerase I (2 U) was performed in 20 µL of topoisomerase I 
relaxation buffer [10mM Tris-HCl, pH 7.9, 1 mM EDTA, 150 
mM NaCl, 0.1% (w/v) BSA, 0.1 mM spermidine, 5% (v/v) 
glycerol] in the presence and absence of varying amounts of the 
test compounds dissolved in dimethyl sulfoxide (5% (v/v) final 5 
concentration). Reactions were started by addition of DNA. 
Control groups were either DNA alone or DNA treated with 
topoisomerase. After 30 min at 37°C, the reaction was terminated 
by addition of 1% (w/v) SDS and digested with 50 mg/mL 
proteinase K at 55°C for 30 min. DNA was extracted with an 10 
equal volume of chloroform/isoamyl alcohol (24:1) and separated 
on 1% (w/v) agarose gel in Tris-acetate-EDTA (TAE) buffer (40 
mM Tris-acetate, pH 8.0, and 2 mM EDTA) at 2 V/cm for 3.5 h. 
Gels were stained with 5 mg/mL ethidium bromide, destained, 
and photographed using Polaroid 665 film or a gel-imaging 15 
system for numerical quantification by densitometry scanning 
(Herolab, Wiesloch,Germany).    
The effect of racemic 2, (12R,28S,31S)-2 (2a) and (12S, 28R, 
31R)-2 (2b) on topoisomerases was investigated using a 
conventional plasmid DNA relaxation assay. HCPT, a well-20 
known Topo I inhibitor, was employed as a positive control. 
(12R, 28S, 31S)-2 (2a) leads to the observed moderate inhibited 
the DNA relaxation activity of Topo I at the concentration of 100 
µM.  
Computational section  25 
Conformational searches were carried out by means of the 
Macromodel 9.7.21118 software using Merck Molecular Force 
Field (MMFF) with implicit solvent model for octanol. In order 
to decrease the number of conformers (246 and 405 for the 
truncated model of 1 and compound 2, respectively, within 21 30 
kJ/mol energy window), the MMFF geometries were reclustered 
for all heavy atoms except for carbons 16-19 and 36-39. 
Geometry reoptimizations at B3LYP/6-31G(d) level of theory 
followed by TD-DFT calculations using various functionals 
(B3LYP, BH&HLYP, PBE0) and 6-311G(d,p) basis set were 35 
performed by the Gaussian 0319 package. Boltzmann distributions 
were estimated from the ZPVE corrected B3LYP/6-31G(d) 
energies. ECD spectra were generated as the sum of Gaussians20 
with 1800 and 3000 cm–1 half-height width (corresponding to ca. 
19 and 32 nm at 325 nm, respectively), using dipole-velocity 40 
computed rotational strengths for conformers above 3%. The 
MOLEKEL21 software package was used for visualization of the 
results. 
Conclusions 
Effusin A (1) and dihydrocryptoechinuline D (2), two new spiro-45 
polyketide-diketopiperazines were isolated from the fungus 
Aspergillus effuses H1-1. Effusin A (1) possesed an  
unprecedented 3',3a',5',6'-tetrahydrospiro[piperazine-2,2'-
pyrano[2,3,4-de]chromene] skeleton, and 2a showed antitumor 
activity targeted to the topoisomerase I. 50 
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